State Ledger
Company profile

Abpro Holdings, Inc. CIK 1893219

Tickers
ABPO (OTC) · ABPWW (OTC)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
New York, NY 10013
Fiscal year end
2025 (FY)
Market Data
Close
$0.02
Change
+$0.00
Change %
0.00%
Volume
0

ABPWW · trading date Oct 12, 2026 · previous close $0.02 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
—
Total assets
$1.06M
Total liabilities
—
Stockholders' equity
-$8.83M
Cash & equivalents
$82.0K
Operating income
-$8.45M
Operating cash flow
-$6.01M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-04-15. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
-830.8%
CapEx / revenue
—
Operating cash flow / net income
—

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — — $1.06M — -$8.83M
2024 $183.0K — $4.66M $19.61M -$15.50M
2023 $122.0K $2.82M $3.36M $16.19M -$88.98M
2022 — $886.9K $310.56M $15.29M -$11.18M
2021 — — $361.4K $338.2K $23.2K
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-01
Financials filed via
Form 10-K
filed 2026-04-15

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New York, NY 10013
6 ST JOHNS LANE, FLOOR 5
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:46 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies